{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:28:13Z","timestamp":1760646493704,"version":"3.40.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Mental Health and Drug and Alcohol Office, NSW Health"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.drugpo.2016.06.006","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T10:05:56Z","timestamp":1465898756000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Alprazolam use and related harm among opioid substitution treatment clients \u2013 12 months follow up after regulatory rescheduling"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0877-3089","authenticated-orcid":false,"given":"Rachel M.","family":"Deacon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-7783","authenticated-orcid":false,"given":"Tim","family":"Cubitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2592-7238","authenticated-orcid":false,"given":"Lauren A.","family":"Monds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Ezard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briony","family":"Larance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Lintzeris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.drugpo.2016.06.006_bib0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","article-title":"The diagnosis and management of benzodiazepine dependence","volume":"18","author":"Ashton","year":"2005","journal-title":"Current Opinion in Psychiatry"},{"year":"2014","series-title":"National opioid pharmacotherapy statistics 2013. Drug treatment series no. 23. Cat. no. HSE 147","author":"Australian Institute of Health and Welfare","key":"10.1016\/j.drugpo.2016.06.006_bib0010"},{"issue":"1","key":"10.1016\/j.drugpo.2016.06.006_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: A meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.drugpo.2016.06.006_bib0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research","volume":"2","author":"Bastien","year":"2001","journal-title":"Sleep Medicine"},{"issue":"3","key":"10.1016\/j.drugpo.2016.06.006_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10550880802122620","article-title":"The impact of benzodiazepine use on methadone maintenance treatment outcomes","volume":"27","author":"Brands","year":"2008","journal-title":"Journal of Addictive Diseases"},{"issue":"6","key":"10.1016\/j.drugpo.2016.06.006_bib0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5694\/j.1326-5377.2004.tb06293.x","article-title":"The effects of restricting publicly subsidised temazepam capsules on benzodiazepine use among injecting drug users in Australia","volume":"181","author":"Breen","year":"2004","journal-title":"Medical Journal of Australia"},{"issue":"4","key":"10.1016\/j.drugpo.2016.06.006_bib0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1753-6405.2010.00573.x","article-title":"Medications used in overdose and how they are acquired \u2013 An investigation of cases attending an inner Melbourne emergency department","volume":"34","author":"Buykx","year":"2010","journal-title":"Australian and New Zealand Journal of Public Health"},{"issue":"1","key":"10.1016\/j.drugpo.2016.06.006_bib0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-244X-11-90","article-title":"Benzodiazepine use and misuse among patients in a methadone program","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.drugpo.2016.06.006_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0376-8716(92)90005-W","article-title":"Benzodiazepine use and HIV risk-taking behaviour among injecting drug users","volume":"31","author":"Darke","year":"1992","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.drugpo.2016.06.006_bib0050","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1465-3362.2009.00101.x","article-title":"Benzodiazepine use among heroin users: Baseline use, current use and clinical outcome","volume":"29","author":"Darke","year":"2010","journal-title":"Drug and Alcohol Review"},{"issue":"S1","key":"10.1016\/j.drugpo.2016.06.006_bib0055","first-page":"23L 24","article-title":"Drug use trends among opioid treatment program clients in south-eastern Sydney","volume":"33","author":"Deacon","year":"2014","journal-title":"Drug and Alcohol Review"},{"issue":"2","key":"10.1016\/j.drugpo.2016.06.006_bib0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09595230701829413","article-title":"The effects of the market withdrawal of temazepam gel capsules on benzodiazepine injecting in Sydney, Australia","volume":"27","author":"Degenhardt","year":"2008","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"10.1016\/j.drugpo.2016.06.006_bib0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hup.2512","article-title":"New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening","volume":"31","author":"Heikman","year":"2016","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"3","key":"10.1016\/j.drugpo.2016.06.006_bib0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.addbeh.2011.11.025","article-title":"Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances \u2013 Systematic review and meta-analysis","volume":"37","author":"Hjorth\u00f8j","year":"2012","journal-title":"Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.drugpo.2016.06.006_bib0075","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1465-3362.2011.00381.x","article-title":"The use of alprazolam by people who inject drugs in Melbourne, Australia","volume":"31","author":"Horyniak","year":"2012","journal-title":"Drug and Alcohol Review"},{"issue":"3","key":"10.1016\/j.drugpo.2016.06.006_bib0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0376-8716(93)90090-D","article-title":"Benzodiazepine and sedative use\/abuse by methadone maintenance clients","volume":"32","author":"Iguchi","year":"1993","journal-title":"Drug and Alcohol Dependence"},{"year":"2015","series-title":"Medicines use and spending shifts: A review of the use of medicines in the U.S. in 2014","author":"IMS Institute for Healthcare Informatics","key":"10.1016\/j.drugpo.2016.06.006_bib0085"},{"issue":"1","key":"10.1016\/j.drugpo.2016.06.006_bib0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2125.2004.02089.x","article-title":"Alprazolam is relatively more toxic than other benzodiazepines in overdose","volume":"58","author":"Isbister","year":"2004","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.drugpo.2016.06.006_bib0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/imj.12315","article-title":"Twenty-year trends in benzodiazepine dispensing in the Australian population","volume":"44","author":"Islam","year":"2014","journal-title":"Internal Medicine Journal"},{"key":"10.1016\/j.drugpo.2016.06.006_bib0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2015.7799","article-title":"Effect of US drug enforcement administration's rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing","author":"Jones","year":"2016","journal-title":"JAMA Internal Medicine"},{"issue":"11","key":"10.1016\/j.drugpo.2016.06.006_bib0105","first-page":"862","article-title":"Benzodiazepine prescribing and violence: Implications for general practitioners","volume":"40","author":"Jones","year":"2011","journal-title":"Australian Family Physician"},{"issue":"3","key":"10.1016\/j.drugpo.2016.06.006_bib0110","first-page":"393","article-title":"Factors affecting the outcome of methadone maintenance treatment in opiate dependence","volume":"100","author":"Kamal","year":"2007","journal-title":"Irish Medical Journal"},{"issue":"1\u20133","key":"10.1016\/j.drugpo.2016.06.006_bib0115","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.drugalcdep.2008.07.017","article-title":"Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: Correlates of use, abuse and dependence","volume":"99","author":"Lavie","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2016.06.006_bib0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1521-0391.2009.00007.x","article-title":"Benzodiazepines, methadone and buprenorphine: Interactions and clinical management","volume":"19","author":"Lintzeris","year":"2010","journal-title":"American Journal on Addictions"},{"year":"1995","series-title":"Manual for the depression anxiety stress scales","author":"Lovibond","key":"10.1016\/j.drugpo.2016.06.006_bib0125"},{"issue":"6","key":"10.1016\/j.drugpo.2016.06.006_bib0130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4414\/sanp.2005.01626","article-title":"Benzodiazepine use in a methadone maintenance programme: Patient characteristics and the physician's dilemma","volume":"156","author":"Meiler","year":"2005","journal-title":"Schweizer Archiv f\u00fcr Neurologie und Psychiatrie"},{"issue":"3","key":"10.1016\/j.drugpo.2016.06.006_bib0135","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/0004867411432074","article-title":"The role of alprazolam for the treatment of panic disorder in Australia","volume":"46","author":"Moylan","year":"2012","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"5","key":"10.1016\/j.drugpo.2016.06.006_bib0140","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/JCP.0b013e31822d0012","article-title":"The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder","volume":"31","author":"Moylan","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.drugpo.2016.06.006_bib0145","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.drugpo.2016.06.006_bib0150","series-title":"National prescribing service newsletter","first-page":"5","author":"National Prescribing Service","year":"1999"},{"key":"10.1016\/j.drugpo.2016.06.006_bib0155","series-title":"Report commissioned by the Ministerial Council on Drug Strategy through the Cost Shared Funding Model with the Victorian Department of Human Services","article-title":"Investigation of pharmaceutical misuse amongst drug treatment clients","author":"Nielsen","year":"2008"},{"issue":"4","key":"10.1016\/j.drugpo.2016.06.006_bib0160","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1360-0443.2006.01731.x","article-title":"Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment","volume":"102","author":"Nielsen","year":"2007","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugpo.2016.06.006_bib0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/appi.ps.201300419","article-title":"Datapoints: Regional variation in benzodiazepine prescribing for patients on opioid agonist therapy","volume":"65","author":"Park","year":"2014","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.drugpo.2016.06.006_bib0170","first-page":"350","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: Case-cohort study","author":"Park","year":"2015","journal-title":"British Medical Journal"},{"issue":"2\u20133","key":"10.1016\/j.drugpo.2016.06.006_bib0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2009.09.013","article-title":"15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel","volume":"107","author":"Peles","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2016.06.006_bib0180","unstructured":"Poisons and Therapeutic Goods Act. (1966) [statute on the internet]. http:\/\/www.legislation.nsw.gov.au\/viewtop\/inforce\/act+31+1966+FIRST+0+N\/."},{"issue":"4","key":"10.1016\/j.drugpo.2016.06.006_bib0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5694\/mja12.10986","article-title":"Recent increase in detection of alprazolam in Victorian heroin-related deaths","volume":"198","author":"Rintoul","year":"2013","journal-title":"Medical Journal of Australia"},{"issue":"3","key":"10.1016\/j.drugpo.2016.06.006_bib0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.NMD.0000054930.03048.64","article-title":"Utility of the time-line follow-back to assess substance use among homeless adults","volume":"191","author":"Sacks","year":"2003","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.drugpo.2016.06.006_bib0195","series-title":"Measuring alcohol consumption: Psychosocial and biological methods","first-page":"41","article-title":"Timeline follow-back: A technique for assessing self-reported ethanol consumption","author":"Sobell","year":"1992"},{"year":"2013","series-title":"Findings from the Illicit Drug Reporting System (IDRS) Australian Drug Trends 2013. Sydney","author":"Stafford","key":"10.1016\/j.drugpo.2016.06.006_bib0200"},{"volume":"Vol. D-39","year":"2013","author":"Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.drugpo.2016.06.006_bib0205"},{"year":"2013","series-title":"eTG complete: Psychotropic guidelines. Melbourne","author":"Therapeutic Guidelines Limited","key":"10.1016\/j.drugpo.2016.06.006_bib0210"},{"key":"10.1016\/j.drugpo.2016.06.006_bib0215","unstructured":"Truven Health Analytics Micromedex. Greenwood Village, CO, USA."},{"issue":"6","key":"10.1016\/j.drugpo.2016.06.006_bib0220","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"2","key":"10.1016\/j.drugpo.2016.06.006_bib0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0376-8716(91)90044-Y","article-title":"Physical dependence on benzodiazepines: Differences within the class","volume":"29","author":"Wolf","year":"1991","journal-title":"Drug and Alcohol Dependence"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395916301761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395916301761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T18:05:33Z","timestamp":1656698733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395916301761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":45,"alternative-id":["S0955395916301761"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2016.06.006","relation":{},"ISSN":["0955-3959"],"issn-type":[{"type":"print","value":"0955-3959"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alprazolam use and related harm among opioid substitution treatment clients \u2013 12 months follow up after regulatory rescheduling","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2016.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}